HA
Halberd Corporation
HALB · OTC
$0.00 +12.50% (+$0.00)
1M +12.50%
Market Cap $464.3K
P/E Ratio -
Div. Yield -
ROE 8.98%
Piotroski F-Score Weak
0/9Valuation
0 /100
Expensive P/S 464.75x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 42.44%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 7,975.58%
Op. margin 7,512.51%
FCF margin 5,169.17%
Quality
42 /100
Average ROE 8.98%
ROA 786.46%
Asset turnover 0.10x
Debt
50 /100
Moderate Int. coverage -16.22x
Net debt/EBITDA -1.95x
Current ratio 0.01x
Stability
3 /100
Unstable Rev. volatility 68.02%
EPS volatility 73.42%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na HALB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William A. Hartman
Employees
3
Headquarters
Jackson Center